Literature DB >> 19919306

Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus.

Soo-Jin Yang1, Barry N Kreiswirth, George Sakoulas, Michael R Yeaman, Yan Q Xiong, Ayumi Sawa, Arnold S Bayer.   

Abstract

Using isogenic clinical bloodstream Staphylococcus aureus strains from a patient with relapsing endocarditis, we investigated the transcriptional profiles of the mprF and dlt genes in the context of cell-surface charge and daptomycin nonsusceptibility. As in prior studies, a point mutation within mprF was observed in the daptomycin-nonsusceptible strain. However, neither the transcriptional profile of mprF nor the membrane phospholipid analyses were compatible with the anticipated mprF gain-in-function phenotype. In contrast, we demonstrated enhanced dlt expression coincident with increased positive surface charge and reduced daptomycin binding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19919306      PMCID: PMC2779839          DOI: 10.1086/648473

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.

Authors:  Christopher Weidenmaier; Andreas Peschel; Volkhard A J Kempf; Natalie Lucindo; Michael R Yeaman; Arnold S Bayer
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry.

Authors:  Kasturi Mukhopadhyay; William Whitmire; Yan Q Xiong; Jaime Molden; Tiffanny Jones; Andreas Peschel; Petra Staubitz; Jill Adler-Moore; Peter J McNamara; Richard A Proctor; Michael R Yeaman; Arnold S Bayer
Journal:  Microbiology       Date:  2007-04       Impact factor: 2.777

3.  Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices.

Authors:  Michael R Yeaman; Kimberly D Gank; Arnold S Bayer; Eric P Brass
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action.

Authors:  M R Yeaman; A S Bayer; S P Koo; W Foss; P M Sullam
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

5.  A LysR-type regulator, CidR, is required for induction of the Staphylococcus aureus cidABC operon.

Authors:  Soo-Jin Yang; Kelly C Rice; Raquel J Brown; Toni G Patton; Linda E Liou; Yong Ho Park; Kenneth W Bayles
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

6.  Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus.

Authors:  Jared A Silverman; Nancy G Perlmutter; Howard M Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

7.  The antimicrobial peptide-sensing system aps of Staphylococcus aureus.

Authors:  Min Li; David J Cha; Yuping Lai; Amer E Villaruz; Daniel E Sturdevant; Michael Otto
Journal:  Mol Microbiol       Date:  2007-10-24       Impact factor: 3.501

8.  Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus.

Authors:  Nagendra N Mishra; Soo-Jin Yang; Ayumi Sawa; Aileen Rubio; Cynthia C Nast; Michael R Yeaman; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

9.  Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus.

Authors:  Yan Q Xiong; Kasturi Mukhopadhyay; Michael R Yeaman; Jill Adler-Moore; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

10.  A synthetic congener modeled on a microbicidal domain of thrombin- induced platelet microbicidal protein 1 recapitulates staphylocidal mechanisms of the native molecule.

Authors:  Yan Q Xiong; Arnold S Bayer; Lisa Elazegui; Michael R Yeaman
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

View more
  68 in total

1.  Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment.

Authors:  Chen-Hsiang Lee; Ming-Chung Wang; I-Wen Huang; Feng-Jui Chen; Tsai-Ling Lauderdale
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

Review 2.  Evolving resistance among Gram-positive pathogens.

Authors:  Jose M Munita; Arnold S Bayer; Cesar A Arias
Journal:  Clin Infect Dis       Date:  2015-09-15       Impact factor: 9.079

Review 3.  Mechanisms of drug resistance: daptomycin resistance.

Authors:  Truc T Tran; Jose M Munita; Cesar A Arias
Journal:  Ann N Y Acad Sci       Date:  2015-10-23       Impact factor: 5.691

4.  Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus dsp1 and asp23.

Authors:  Elaine M Barros; Melissa J Martin; Elizabeth M Selleck; François Lebreton; Jorge Luiz M Sampaio; Michael S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 5.  Envelope Structures of Gram-Positive Bacteria.

Authors:  Mithila Rajagopal; Suzanne Walker
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

6.  In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.

Authors:  Nagendra N Mishra; James McKinnell; Michael R Yeaman; Aileen Rubio; Cynthia C Nast; Liang Chen; Barry N Kreiswirth; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 7.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients.

Authors:  Nagendra N Mishra; Arnold S Bayer; Pamela A Moise; Michael R Yeaman; George Sakoulas
Journal:  J Infect Dis       Date:  2012-08-16       Impact factor: 5.226

9.  Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.

Authors:  Molly E Steed; Brian J Werth; Cortney E Ireland; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 10.  [Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].

Authors:  Sandra Rincón; Diana Panesso; Lorena Díaz; Lina P Carvajal; Jinnethe Reyes; José M Munita; César A Arias
Journal:  Biomedica       Date:  2014-04       Impact factor: 0.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.